TBC1D17
TBC1 domain family member 17
Also known as: FLJ12168, TBC17_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HA65
- Gene
- TBC1D17
- Ensembl
- ENSG00000104946
- Chromosome
- 19
- Canonical length
- 648 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable GTPase activator activity. Involved in retrograde transport, endosome to Golgi. Located in cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
648 residues, UniProt reviewed canonical sequence.
>Q9HA65|TBC1D17
1 MEGAGYRVVF EKGGVYLHTS AKKYQDRDSL IAGVIRVVEK DNDVLLHWAP VEEAGDSTQI
61 LFSKKDSSGG DSCASEEEPT FDPGYEPDWA VISTVRPQLC HSEPTRGAEP SCPQGSWAFS
121 VSLGELKSIR RSKPGLSWAY LVLVTQAGGS LPALHFHRGG TRALLRVLSR YLLLASSPQD
181 SRLYLVFPHD SSALSNSFHH LQLFDQDSSN VVSRFLQDPY STTFSSFSRV TNFFRGALQP
241 QPEGAASDLP PPPDDEPEPG FEVISCVELG PRPTVERGPP VTEEEWARHV GPEGRLQQVP
301 ELKNRIFSGG LSPSLRREAW KFLLGYLSWE GTAEEHKAHI RKKTDEYFRM KLQWKSVSPE
361 QERRNSLLHG YRSLIERDVS RTDRTNKFYE GPENPGLGLL NDILLTYCMY HFDLGYVQGM
421 SDLLSPILYV IQNEVDAFWC FCGFMELVQG NFEESQETMK RQLGRLLLLL RVLDPLLCDF
481 LDSQDSGSLC FCFRWLLIWF KREFPFPDVL RLWEVLWTGL PGPNLHLLVA CAILDMERDT
541 LMLSGFGSNE ILKHINELTM KLSVEDVLTR AEALHRQLTA CPELPHNVQE ILGLAPPAEP
601 HSPSPTASPL PLSPTRAPPT PPPSTDTAPQ PDSSLEILPE EEDEGADSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TBC1D17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 132 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 132 nTPM
- cerebral cortex: 49 nTPM
- skin: 45 nTPM
- blood vessel: 44 nTPM
- spinal cord: 42 nTPM
- basal ganglia: 40 nTPM
Single-cell type
- oocytes: 341 nCPM
- syncytiotrophoblasts: 89 nCPM
- cytotrophoblasts: 60 nCPM
- innate lymphoid cells: 59 nCPM
- rod photoreceptor cells: 43 nCPM
- retinal horizontal cells: 42 nCPM
Immune cell
- basophil: 14 nTPM
- naive B-cell: 11 nTPM
- NK-cell: 11 nTPM
- eosinophil: 8.5 nTPM
- memory CD8 T-cell: 8.3 nTPM
- memory B-cell: 8.1 nTPM
Brain region
- white matter: 78 nTPM
- medulla oblongata: 77 nTPM
- basal ganglia: 67 nTPM
- pons: 67 nTPM
- cerebellum: 64 nTPM
- cerebral cortex: 63 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TBC1D17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TBC1D17 as an antibody target. Whether an autoantibody or antibody against TBC1D17 could matter depends on whether native TBC1D17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TBC1D17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TBC1D17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...